Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
Zacks.com on MSN2d
RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded UseUltragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce trigl ...
The Food and Drug Administration (FDA) has approved Liraglutide Injection ... It is indicated for use as an adjunct to diet and exercise to improve glycemic control in adults and pediatric ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback